• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基质金属蛋白酶和金属蛋白酶组织抑制因子在人乳腺癌组织中的表达及其平衡在癌症侵袭和转移中的重要性]

[The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].

作者信息

Iwata H, Kobayashi S, Iwase H, Okada Y

机构信息

Second Department of Surgery, Nagoya City University Medical School.

出版信息

Nihon Rinsho. 1995 Jul;53(7):1805-10.

PMID:7630023
Abstract

Tumor cells degrade extracellular matrix components (ECM) to invade surrounding tissues. Malignant tumor cells are known to produce various ECM-degrading enzymes including matrix metalloproteinases (MMPs), serine proteinases and cathepsins. Among them, MMPs may play a key role in cancer invasion and metastasis. To study the role of MMPs in the progression of human breast carcinomas, we examined production and tissue localization of MMP-1, MMP-2, MMP-3, MMP-9 and their common inhibitors, tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). The data suggest that the imbalance between MMPs and TIMPs produced by tumor tissues may be a determinant of the progression in breast carcinoma.

摘要

肿瘤细胞通过降解细胞外基质成分(ECM)来侵袭周围组织。已知恶性肿瘤细胞会产生多种ECM降解酶,包括基质金属蛋白酶(MMPs)、丝氨酸蛋白酶和组织蛋白酶。其中,MMPs可能在癌症侵袭和转移中起关键作用。为了研究MMPs在人类乳腺癌进展中的作用,我们检测了MMP-1、MMP-2、MMP-3、MMP-9及其常见抑制剂金属蛋白酶组织抑制剂(TIMP-1和TIMP-2)的产生和组织定位。数据表明,肿瘤组织产生的MMPs和TIMPs之间的失衡可能是乳腺癌进展的一个决定因素。

相似文献

1
[The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis].[基质金属蛋白酶和金属蛋白酶组织抑制因子在人乳腺癌组织中的表达及其平衡在癌症侵袭和转移中的重要性]
Nihon Rinsho. 1995 Jul;53(7):1805-10.
2
[Molecular biology of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), and the regulation of these genes in tumor tissues].[基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)的分子生物学,以及这些基因在肿瘤组织中的调控]
Nihon Rinsho. 1995 Jul;53(7):1791-7.
3
Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.免疫反应性基质金属蛋白酶和基质金属蛋白酶组织抑制剂在人正常肝脏和原发性肝肿瘤中的表达。
Hepatology. 1996 Jun;23(6):1341-4. doi: 10.1053/jhep.1996.v23.pm0008675149.
4
Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.肿瘤细胞与基质的相互作用:细胞周围基质降解与转移
Verh Dtsch Ges Pathol. 2000;84:33-42.
5
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.与周围非肿瘤组织相比,基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)在肝细胞癌组织中的表达情况。
Res Commun Mol Pathol Pharmacol. 2004;115-116:143-50.
6
Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.基质金属蛋白酶(MMP - 2、MMP - 9、MT1 - MMP)及其抑制剂(TIMP - 1、TIMP - 2)在卵巢常见上皮性肿瘤中的表达
Int J Oncol. 2000 Oct;17(4):673-81.
7
[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].[基质金属蛋白酶-9、2、7及金属蛋白酶组织抑制剂-1、2、3 mRNA在卵巢肿瘤中的表达及其临床意义]
Ai Zheng. 2004 Oct;23(10):1194-8.
8
Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.卵巢肿瘤囊液中基质金属蛋白酶及相关组织抑制剂的分析
Hokkaido Igaku Zasshi. 1999 Mar;74(2):145-55.
9
Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.膜型1、2和3基质金属蛋白酶在人浸润性乳腺癌中的表达及组织定位
Cancer Res. 1997 May 15;57(10):2055-60.
10
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].[基质金属蛋白酶-2、9及其抑制剂-基质金属蛋白酶组织抑制因子1、2在子宫颈鳞状细胞癌中的表达]
Ai Zheng. 2002 Jul;21(7):735-9.

引用本文的文献

1
FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.FAM83B 通过 PI3K/AKT/NF-κB 通路促进原发性肺腺癌的侵袭。
BMC Pulm Med. 2023 Jan 23;23(1):32. doi: 10.1186/s12890-022-02303-5.
2
3,4-Dihydroxybenzalactone Suppresses Human Non-Small Cell Lung Carcinoma Cells Metastasis via Suppression of Epithelial to Mesenchymal Transition, ROS-Mediated PI3K/AKT/MAPK/MMP and NFκB Signaling Pathways.3,4-二羟基苯并内酯通过抑制上皮-间质转化、ROS介导的PI3K/AKT/MAPK/MMP和NFκB信号通路来抑制人非小细胞肺癌细胞转移。
Molecules. 2017 Mar 28;22(4):537. doi: 10.3390/molecules22040537.
3
Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness.
盐酸青藤碱通过减轻炎症相关的上皮-间质转化和癌症干性来抑制乳腺癌转移。
Oncotarget. 2017 Feb 21;8(8):13560-13574. doi: 10.18632/oncotarget.14593.
4
The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action.氧硫胺的体外和体内抗转移功效及其可能的作用机制。
Clin Exp Metastasis. 2010 May;27(5):341-9. doi: 10.1007/s10585-010-9331-2. Epub 2010 May 7.
5
Proteolysis in human breast cancer.人类乳腺癌中的蛋白水解作用。
Mol Pathol. 2000 Apr;53(2):99-106. doi: 10.1136/mp.53.2.99.